These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 15824410
1. The analysis by Manuel and colleagues creates controversy with headlines, not data. Genest J, McPherson R, Frohlich J, Fodor G. CMAJ; 2005 Apr 12; 172(8):1033-4; discussion 1037. PubMed ID: 15824410 [No Abstract] [Full Text] [Related]
2. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed. Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A. CMAJ; 2005 Apr 12; 172(8):1027-31. PubMed ID: 15824409 [No Abstract] [Full Text] [Related]
3. New Therapies in the Treatment of High Cholesterol: An Argument to Return to Goal-Based Lipid Guidelines. Shrank WH, Barlow JF, Brennan TA. JAMA; 2015 Oct 13; 314(14):1443-4. PubMed ID: 26258765 [No Abstract] [Full Text] [Related]
4. [Guideline for management of lipid metabolism]. Ishibashi S. Nihon Rinsho; 2002 Sep 13; 60 Suppl 9():675-8. PubMed ID: 12387068 [No Abstract] [Full Text] [Related]
5. Combination therapy for elevated low-density lipoprotein cholesterol: the key to coronary artery disease risk reduction. McKenney J. Am J Cardiol; 2002 Nov 20; 90(10B):8K-20K. PubMed ID: 12467936 [Abstract] [Full Text] [Related]
6. [Drug combination therapies for patients with hyperlipidemia and its significance]. Onuma T, Kawamori R. Nihon Rinsho; 2001 Mar 20; 59 Suppl 3():566-71. PubMed ID: 11347133 [No Abstract] [Full Text] [Related]
7. [Statins (HMG-CoA reductase inhibitors)]. Gotoda T. Nihon Rinsho; 2006 Nov 20; 64(11):2113-8. PubMed ID: 17087305 [Abstract] [Full Text] [Related]
8. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease. Borgia MC, Medici F. Angiology; 1998 May 20; 49(5):339-48. PubMed ID: 9591525 [Abstract] [Full Text] [Related]
9. Beyond statins: what to expect from add-on lipid regulating therapy? Laufs U, Weintraub WS, Packard CJ. Eur Heart J; 2013 Sep 20; 34(34):2660-5. PubMed ID: 23832488 [No Abstract] [Full Text] [Related]
11. Normocholesterolaemic dysslipidaemia: is there a role for fibrates? Hamilton-Craig I. Med J Aust; 2001 Jun 04; 174(11):610; author reply 611. PubMed ID: 11453341 [No Abstract] [Full Text] [Related]
12. [Hyperlipidemia in the elderly]. Kawano M. Nihon Rinsho; 2002 May 04; 60(5):1017-23. PubMed ID: 12029980 [Abstract] [Full Text] [Related]
13. [Dyslipidemia in renal failure]. Fujioka T, Ueno T, Matsumoto T, Watanabe H. Nihon Rinsho; 2004 Jun 04; 62 Suppl 6():118-23. PubMed ID: 15250280 [No Abstract] [Full Text] [Related]
14. Pharmacotherapy of dyslipidemia. McKenney JM. Cardiovasc Drugs Ther; 2001 Sep 04; 15(5):413-22. PubMed ID: 11855660 [Abstract] [Full Text] [Related]
16. Trials of lipid-lowering therapy in secondary prevention of coronary heart disease. Olsson AG, Pedersen T, Bergdahl B. Curr Opin Lipidol; 1995 Dec 04; 6(6):369-73. PubMed ID: 8750250 [Abstract] [Full Text] [Related]
17. Statins for stroke: the second story? Plutzky J, Ridker PM. Circulation; 2001 Jan 23; 103(3):348-50. PubMed ID: 11157683 [No Abstract] [Full Text] [Related]
18. [Clinical trials on protective efficacy of statins for cardiovascular events due to hyperlipidemia (J-LIT, 4S, CARE, LIPID etc)]. Higashikata T. Nihon Rinsho; 2004 Mar 23; 62 Suppl 3():628-36. PubMed ID: 15171447 [No Abstract] [Full Text] [Related]
20. Switching to statins: a challenge for primary care. Fisher NG, Marshall AJ, Went J. J R Soc Med; 1999 Oct 25; 92(10):522-4. PubMed ID: 10692904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]